CoChat

A randomised, double-blind, placebo controlled cross-over study to determine the gastrointestinal effects of consumption of arabinoxylan-oligosaccharides enriched bread in healthy volunteers

Open access
Walton, Gemma E, Lu, Congyi, Trogh, Isabel, Arnaut, Filip, Gibson, Glenn R · 2012 · Nutrition Journal
Cited by 116

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Prebiotics are food ingredients, usually non-digestible oligosaccharides, that are selectively fermented by populations of beneficial gut bacteria. Endoxylanases, altering the naturally present cereal arabinoxylans, are commonly used in the bread industry to improve dough and bread characteristics. Recently, an in situ method has been developed to produce arabinoxylan-oligosaccharides (AXOS) at high levels in breads through the use of a thermophilic endoxylanase. AXOS have demonstrated potentially prebiotic properties in that they have been observed to lead to beneficial shifts in the microbiota in vitro and in murine, poultry and human studies. METHODS: A double-blind, placebo controlled human intervention study was undertaken with 40 healthy adult volunteers to assess the impact of consumption of breads with in situ produced AXOS (containing 2.2 g AXOS) compared to non-endoxylanase treated breads. Volatile fatty acid concentrations in faeces were assessed and fluorescence in situ hybridisation was used to assess changes in gut microbial groups. Secretory immunoglobulin A (sIgA) levels in saliva were also measured. RESULTS: Consumption of AXOS-enriched breads led to increased faecal butyrate and a trend for reduced iso-valerate and fatty acids associated with protein fermentation. Faecal levels of bifidobacteria increased following initial control breads and remained elevated throughout the study. Lactobacilli levels were elevated following both placebo and AXOS-breads. No changes in salivary secretory IgA levels were observed during the study. Furthermore, no adverse effects on gastrointestinal symptoms were reported during AXOS-bread intake. CONCLUSIONS: AXOS-breads led to a potentially beneficial shift in fermentation end products and are well tolerated.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/1475-2891-11-36

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Research works printed but not linked: 60

  1. Dubert-Ferrandon A, Newburg DS, Walker WA: Part 2-Prebiotics: New medicines for the colon, health benefits. Nutr Today. 2009, 44: 85-91. 10.1097/NT.0b013e31819df7bc. · DOI
  2. Szilagyi A: Prebiotics or probiotics for lactose intolerance: a question of adaptation. Am J Clin Nutr. 1999, 70 (1): 105-106. · doi:10.1093/ajcn/70.1.105
  3. Evenepoel P, Meijers BK, Bammens BR, Verbeke K: Uremic toxins originating from colonic microbial metabolism. Kidney Int. 2009, 144 (Suppl): 12-19. · DOI · Paper page
  4. Ooi L, Liong M: Cholesterol-lowering effects of probiotics and prebiotics: a review of in vivo and in vitro findings. Int J Mol Sci. 2010, 11: 2499-2522. 10.3390/ijms11062499. · DOI · Paper page
  5. Abrams SA, Griffin IJ, Hawthorne KM, Liang L, Gunn SK, Darlington G, Ellis KJ: A combination of prebiotic short and long-chain inulin-type fructans enhances calcium absorption and bone mineralization in young adolescents. Am J Clin Nutr. 2005, 82: 471-476. · DOI · Paper page
  6. Burns AJ, Rowland IR: Antigenotoxicity of probiotics and prebiotics on faecal water-induced DNA damage in human colon adenocarcinoma cells. Muta Res. 2004, 551: 233-243. 10.1016/j.mrfmmm.2004.03.010. · DOI
  7. Klinder A, Förster A, Caderni G, Femia AP, Pool-Zobel BL: Faecal water genotoxicity is predictive of tumor preventive activities by inulin-like oligofructoses, probiotics (Lactobacillus rhamnosus and Bifidobacterium lactis) and their synbiotic combination. Nutr Cancer. 2004, 49: 144-155. 10.1207/s15327914nc4902_5. · DOI · Paper page
  8. Pool-Zobel BL: Inulin-type fructans and reduction in colon cancer risk: review of experimental and human data. Br J Nutr. 2005, 93 (Suppl): 73-90. · DOI · Paper page
  9. Gibson GR: Probiotics and prebiotics and their function. Funct Nutr. 2003, 2: 11-13.
  10. Roberfroid MB: Prebiotics and probiotics: are they functional foods?. Am J Clin Nutr. 2000, 71 (Suppl 6): 1682-1687. · DOI · Paper page
  11. Tuohy KM, Kolida S, Lustenberger AM, Gibson GR: The prebiotic effects of biscuits containing partially hydrolysed guar gum and fructo-oligosaccharides – a human volunteer study. Br J Nutr. 2001, 86: 341-348. 10.1079/BJN2001394. · DOI · Paper page
  12. Costabile A, Kolida S, Klinder A, Gietl E, Bäuerlein M, Frohberg C, Landschütze V, Gibson GR: A double-blind, placebo-controlled, cross-over study to establish the bifidogenic effect of a very-long-chain inulin extracted from globe artichoke (Cynara scolymus) in healthy human subjects. Br J Nutr. 2010, 104: 1007-1017. 10.1017/S0007114510001571. · DOI · Paper page
  13. Ramnani P, Gaudier E, Bingham M, Bruggen P, Van Tuohy KM, Gibson GR: Prebiotic effect of fruit and vegetable shots containing Jerusalem artichoke inulin: a human intervention study. Br J Nutr. 2010, 104: 233-240. 10.1017/S000711451000036X. · DOI · Paper page
  14. Van Haesendonck IPH, Broekaert WF, Georis J, Delcour J, Courtin C, Filip A: Bread with increased arabinoxylo-oligosaccharide content. 2008, Geneva: WIPO, Publication no. WO08087167, Publication no
  15. Kamp JWVD, Asp NG, Jones JM, Schaafsma G: Dietary Fibre — bio-active carbohydrates for food and feed. 2004, The Netherlands: Wageningen Academic Publishers · doi:10.3920/978-90-8686-662-5
  16. Van Craeyveld V, Swennen K, Dornez E, Van de Wiele T, Marzorati M, Verstraete W, Delaedt Y, Onagbesan O, Decuypere E, Buyse J, De Ketelaere B, Broekaert WF, Delcour JA, Courtin CM: Structurally different wheat-derived arabinoxylooligosaccharides have different prebiotic and fermentation properties in rats. Am J Clin Nutr. 2008, 138: 2348-2355.
  17. Sanchez JI, Marzorati M, Grootaert C, Baran M, Van Craeyveld V, Courtin CM, Broekaert WF, Delcour JA, Verstraete W, Van de Wiele T: Arabinoxylan-oligosaccharides (AXOS) affects the protein/carbohydrate fermentation balance and microbial population dynamics of the simulator of human intestinal microbial ecosystem. Microb Biotechnol. 2009, 2: 101-113. 10.1111/j.1751-7915.2008.00064.x. · DOI · Paper page
  18. Courtin CM, Swennen K, Broekaert WF, Swennen Q, Buyse J, Decuypere E, Michiels CW, De Ketelaere B, Delcour JA: Effects of dietary inclusion of xylooligosaccharides, arabinoxylooligosaccharides and soluble arabinoxylan on the microbial composition of caecal contents of chickens. J Sci Food Agric. 2008, 88: 2517-2522. 10.1002/jsfa.3373. · doi:10.1002/jsfa.3373
  19. Cloetens L, Broekaert WF, Delaedt Y, Ollevier F, Courtin CM, Delcour JA, Rutgeerts P, Verbeke K: Tolerance of arabinoxylan-oligosaccharides and their prebiotic activity in healthy subjects: a randomised, placebo-controlled cross-over study. Br J Nutr. 2010, 103: 703-713. 10.1017/S0007114509992248. · DOI · Paper page
  20. Eeckhaut V, Van Immerseel F, Dewulf J, Pasmans F, Haesebrouck F, Ducatelle R, Courtin CM, Delcour JA, Broekaert WF: Arabinoxylooligosaccharides from wheat bran inhibit Salmonella colonization in broiler chickens. Poult Sci. 2008, 87: 2329-2334. 10.3382/ps.2008-00193. · DOI
  21. Cloetens L, De Preter V, Swennen K, Broekaert WF, Courtin CM, Delcour JA, Rutgeerts P, Verbeke K: Dose–response effect of arabinoxylooligosaccharides on gastrointestinal motility and on colonic bacterial metabolism in healthy volunteers. J Am Coll Nutr. 2008, 27: 512-518. · DOI · Paper page
  22. Van Craeyveld V, Swennen K, Dornez E, Van de Wiele T, Marzorati M, Verstraete W, Delaedt Y, Onagbesan O, Decuypere E, Buyse J, De Ketelaere B, Broekaert WF, Delcour JA, Courtin CM: Structurally different wheat-derived arabinoxylooligosaccharides have different prebiotic and fermentation properties in rats. J Nutr. 2008, 138: 2348-2355. 10.3945/jn.108.094367. · DOI · Paper page
  23. Dronamraju SS, Coxhead JM, Kelly SB, Mathers JC: Differential antineoplastic effects of butyrate in cells with and without a functioning DNA mismatch repair. Nutr Cancer. 2010, 62: 105-115. · DOI
  24. Collins JK, Dunne C, Murphy L, Morrissey D, O'Mahony L, O'Sullivan E, Fitzgerald G, Kiely B, O'Sullivan GC, Daly C, Marteau P, Shanahan F: A randomized controlled trial of a probiotic Lactobacillus strain in healthy adults: assessment of its delivery, transit and influence on microbial flora and enteric immunity. Microb Ecol Health Dis. 2002, 14: 81-89. 10.1080/08910600260081720. · DOI
  25. Courtin CM, Van den Broeck H, Delcour JA: Determination of reducing end sugar residues in oligo- and polysaccharides by gas–liquid chromatography. J Chromatogr. 2000, 866: 97-104. 10.1016/S0021-9673(99)01064-X. · DOI
  26. Damen B, Cloetens L, Broekaert WF, François I, Lescroart O, Trogh I, Arnaut F, Welling GW, Wijffels J, Delcour JA, Verbeke K, Courtin CM: Consumption of breads containing in situ-produced arabinoxylan oligosaccharides alters gastrointestinal effects in healthy volunteers. J Nutr. 2012, 142: 470-477. 10.3945/jn.111.146464. · DOI
  27. Martín-Peláez S, Gibson GR, Martín-Orúe SM, Klinder A, Rastall RA, La Ragione RM, Woodward MJ, Costabile A: In vitro fermentation of carbohydrates by porcine faecal inocula and their influence on Salmonella Typhimurium growth in batch culture systems. FEMS Microbiol Ecol. 2008, 66 (3): 608-619. 10.1111/j.1574-6941.2008.00610.x. · DOI
  28. Harmsen HJM, Wildeboer-Veloo ACM, Grijpstra J, Knol J, Degener JE, Welling GW: Development of 16 S rRNA-based probes for the Coriobacterium group and the Atopobium cluster and their application for enumeration of Coriobacteriaceae in human faeces from volunteers of different age groups. Appl Environ Microbiol. 2000, 66: 4523-4527. 10.1128/AEM.66.10.4523-4527.2000. · DOI · Paper page
  29. Manz W, Amann R, Ludwig W, Vancanneyt M, Schleifer KH: Application of a suite of 16 S rRNA-specific oligonucleotide probes designed to investigate bacteria of the phylum cytophaga-flavobacter-bacteroides in the natural environment. Microbiol. 1996, 142: 1097-1106. 10.1099/13500872-142-5-1097. · DOI · Paper page
  30. Langendijk PS, Schut F, Jansen GJ, Raangs GC, Kamphuis GR, Wilkinson MH, Welling GW: Quantitative fluorescence in situ hybridization of Bifidobacterium spp. with genus-specific16S rRNA-targeted probes and its application in faecal samples. Appl Environ Microbiol. 1995, 61: 3069-3075. · DOI · Paper page
  31. Franks AH, Harmsen HJM, Raangs GC, Jansen GJ, Schut F, Welling GW: Variations of bacterial populations in human faeces measured by fluorescence in situ hybridization with group-specific 16 S rRNA-targeted oligonucleotide probes. Appl Environ Microbiol. 1998, 64: 3336-3345. · DOI · Paper page
  32. Harmsen HJM, Elfferich P, Schut F, Welling GW: A16S rRNA-targeted probe for detection of lactobacilli and enterococci in faecal samples by fluorescence in situ hybridization. Microb Ecol Health Dis. 1999, 11: 3-12. 10.1080/089106099435862. · DOI · Paper page
  33. Poulsen LK, Lan F, Kristensen CS, Hobolth P, Molin S, Krogfelt KA: Spatial distribution of Escherichia coli in the mouse large intestine inferred from rRNA in situ hybridization. Infect Immun. 1994, 62: 5191-5194. · DOI · Paper page
  34. Suau A, Rochet V, Sghir A, Gramet G, Brewaeys S, Sutren M, RigottierGois L, Dore J: Fusobacterium prausnitzii and related species represent a dominant group within the human fecal flora. Systems Appl Microbiol. 2001, 24: 139-145. 10.1078/0723-2020-00015. · DOI · Paper page
  35. Daims H, Brühl A, Amann R, Schleifer KH, Wagner M: The domain-specific probe EUB338 is insufficient for the detection of all Bacteria: development and evaluation of a more comprehensive probe set. Syst Appl Microbiol. 1999, 22: 434-444. 10.1016/S0723-2020(99)80053-8. · DOI · Paper page
  36. Richardson AJ, Calder AG, Stewart CS, Smith A: Simultaneous determination of volatile and non-volatile acid fermentation products of anaerobes by capillary gas chromatography. Lett Appl Microbiol. 1989, 9: 5-8. 10.1111/j.1472-765X.1989.tb00278.x. · DOI · Paper page
  37. Böcker U, Nebe T, Herweck F, Holt L, Panja A, Jobin C, Rossol SB, Sartor R: Singer MV: Butyrate modulates intestinal epithelial cell-mediated neutrophil migration. Clin Exp Immunol. 2003, 131: 53-60. 10.1046/j.1365-2249.2003.02056.x. · DOI · Paper page
  38. Mortensen PB, Clausen MR, Bonnén H, Hove H, Holtug K: Colonic fermentation of ispaghula, wheat bran, glucose, and albumin to short-chain fatty acids and ammonia evaluated in vitro in 50 subjects. PEN J Parenter Enteral Nutr. 1992, 16: 433-439. 10.1177/0148607192016005433. · DOI · Paper page
  39. Gibson GR, Scott KP, Rastall RA, Tuohy KM, Hotchkiss A, Dubert-Ferrandon A, Gareau M, Murphy EF, Saulnier D, Loh G, Macfarlane S, Delzenne N, Ringel Y, Kozianowski G, Dickmann R, Lenoir-Wijnkook I, Walker C, Buddington R: Dietary prebiotics: current status and new definition. IFIS Func Foods Bull. 2010, 7: 1-19. · DOI · Paper page
  40. Crittenden R, Karppinen S, Ojanen S, Tenkanen M, Fagerstrom R, Mättö J, Saarela M, Mattila-Sandholm T, Poutanen K: In vitro fermentation of cereal dietary fibre carbohydrates by probiotic and intestinal bacteria. J Sci Food Agric. 2002, 82: 781-789. 10.1002/jsfa.1095. · DOI · Paper page
  41. Kontula P, Suihko ML, Suortti T, Tenkanen M, Mattila-Sandholm T, von Wright A: The isolation of lactic acid bacteria from human colonic biopsies after enrichment on lactose derivatives and rye arabinoxylo-oligosaccharides. Food Microbiol. 2000, 17: 13-22. 10.1006/fmic.1999.0268. · doi:10.1006/fmic.1999.0268
  42. Van Laere KMJ, Hartemink R, Bosveld M, Schols HA, Voragen AGJ: Fermentation of plant cell wall derived polysaccharides and their corresponding oligosaccharides by intestinal bacteria. J Agric Food Chem. 2000, 48: 1644-1652. 10.1021/jf990519i. · DOI · Paper page
  43. Jaskari J, Kontula P, Siitonen A, Jousimies-Somer H, Mattila-Sandholm T, Poutanen K: Oat beta-glucan and xylan hydrolysates as selective substrates for Bifidobacterium and Lactobacillus strains. Appl Microbiol and Biotech. 1998, 49: 175-181. 10.1007/s002530051155. · DOI · Paper page
  44. Venter CS: Prebiotics: an update. JFECS. 2007, 35: 17-25.
  45. Karppinen S, Myllymäki O, Forssell P, Poutanen K: Fructan content of rye and rye products. Cereal Chem. 2003, 80: 168-171. 10.1094/CCHEM.2003.80.2.168. · DOI · Paper page
  46. Davis LM, Martínez I, Walter J, Hutkins R: A dose dependent impact of prebiotic galactooligosaccharides on the intestinal microbiota of healthy adults. Intl J Food Microbiol. 2010, 44: 285-292. · DOI · Paper page
  47. Muller MRA, Ehrmann M, Vogel RF: Lactobacillus frumenti sp. nov., a new lactic acid bacterium isolated from rye-bran fermentations with a long fermentation period. Int J Syst Evol Micr. 2000, 50: 2127-2133. 10.1099/00207713-50-6-2127. · DOI
  48. Vogel RF, Böcker G, Stolz P, Ehrmann M, Fanta D, Ludwig W, Pot B, Kersters K, Schleifer KH, Hammes WP: Identification of lactobacilli from sourdough and description of Lactobacillus pontis sp. nov. Int J Syst Bacteriol. 1994, 44: 223-229. 10.1099/00207713-44-2-223. · DOI · Paper page
  49. Glitso LV, Gruppen H, Schols HA, Hojsgaard S, Sandstrom B, Knudsen KEB: Degradation of rye arabinoxylans in the large intestine of pigs. J Sci Food Agric. 1999, 79: 61-969. · DOI
  50. Chassard C, Goumy V, Leclerc M, Del’homme C, Bernalier-Donadille A: Characterization of the xylan-degrading microbial community from human faeces. FEMS Microbiol Ecol. 2007, 61: 121-131. 10.1111/j.1574-6941.2007.00314.x. · DOI · Paper page
  51. Broekaert WF, Courtin CM, Verbeke K, Van de Wiele T, Verstraete W, Delcour JA: Prebiotic and other health-related effects of cereal-derived arabinoxylans, arabinoxylan-oligosaccharides, and xylooligosaccharides. Crit Rev Food Sci Nutr. 2011, 51: 178-194. 10.1080/10408390903044768. · DOI · Paper page
  52. Rigottier-Gois L, Rochet V, Garrec N, Suau A, Doré J: Enumeration of Bacteroides species in human faeces by fluorescent in situ hybridisation combined with flow cytometry using 16 S rRNA probes. Syst Appl Microbiol. 2003, 26: 110-118. 10.1078/072320203322337399. · DOI
  53. Grootaert C, Van Den Abbeele P, Marzorati M, Broekaert WF, Courtin CM, Delcour JA, Verstraete W, Van De Wiele T: Comparison of prebiotic effects of arabinoxylan oligosaccharides and inulin in a simulator of the human intestinal microbial ecosystem. FEMS Microbiol Ecol. 2009, 69: 231-242. 10.1111/j.1574-6941.2009.00712.x. · DOI · Paper page
  54. Louis P, Flint HJ: Diversity, metabolism and microbial ecology of butyrate-producing bacteria from the human large intestine. FEMS Microbiol Lett. 2009, 294: 1-8. 10.1111/j.1574-6968.2009.01514.x. · DOI · Paper page
  55. Macfarlane GT, Hay S, Macfarlane S, Gibson GR: Effect of different carbohydrates on growth, polysaccharidase and glycosidase production by Bacteroides ovatus, in batch and continuous culture. J Appl Bacteriol. 1990, 68: 179-187. 10.1111/j.1365-2672.1990.tb02564.x. · DOI · Paper page
  56. Macfarlane GT, Cummings JH, Allison C: Protein degradation by human intestinal bacteria. J Gen Microbiol. 1986, 132: 1647-1656.
  57. Mortensen PB, Clausen MR: Short-chain fatty acids in the human colon: relation to gastrointestinal health and disease. Scand J Gastroenterol. 1996, 216 (Suppl): 132-148. · DOI · Paper page
  58. Zeier H, Brauchli P, Joller-Jemelka HI: Effects of work demands on immunoglobulin A and cortisol in air traffic controllers. Biol Psychol. 1996, 42: 413-423. 10.1016/0301-0511(95)05170-8. · DOI
  59. Matos-Gomes N, Katsurayama M, Makimoto FH, Santana LL, Paredes-Garcia E, Becker MA, Dos-Santos MC: Psychological stress and its influence on salivary flow rate, total protein concentration and IgA, IgG and IgM titers. Neuroimmunomodulation. 2010, 17: 396-404. 10.1159/000292064. · DOI
  60. Moreira A, Arsati F, Cury PR, Franciscon C, Simões AC, de Oliveira PR, de Araújo VC: The impact of a 17-day training period for an international championship on mucosal immune parameters in top-level basketball players and staff members. Eur J Oral Sci. 2008, 116: 431-437. 10.1111/j.1600-0722.2008.00558.x. · DOI · Paper page

Cited by

See all 116

Metadata

Authors
Walton, G. E., Lu, C., Trogh, I., Arnaut, F., & Gibson, G. R.
Venue
Nutrition Journal
Published
2012-06-01
Volume
11
Issue
1
Pages
36-36
ISSN
1475-2891 (ISSN-L)
OpenAlex
W2116503555
Cited by
116
References
8
FWCI
6.05
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A randomised, double-blind, placebo controlled cross-over study to determine the gastrointestinal effects of consumption of arabinoxylan-oligosaccharides enriched bread in healthy volunteers. https://app.cochat.ai/papers/10.1186/1475-2891-11-36
The paper
Walton, G. E., Lu, C., Trogh, I., Arnaut, F., & Gibson, G. R. (2012). A randomised, double-blind, placebo controlled cross-over study to determine the gastrointestinal effects of consumption of arabinoxylan-oligosaccharides enriched bread in healthy volunteers. Nutrition Journal. https://doi.org/10.1186/1475-2891-11-36

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.